Vik Chopra
Stock Analyst at Wells Fargo
(2.77)
# 2,202
Out of 4,829 analysts
41
Total ratings
35.29%
Success rate
2.57%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Overweight | $205 → $190 | $163.56 | +16.17% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $13.67 | -4.90% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $70.47 | +6.43% | 2 | May 6, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $70 → $57 | $60.73 | -6.14% | 4 | May 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $255 → $246 | $189.00 | +30.16% | 2 | May 1, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $74.80 | +0.27% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $16.75 | +13.43% | 2 | Feb 28, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $59.01 | +57.60% | 9 | Feb 21, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $18.55 | +13.21% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $13.37 | -2.77% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $12.67 | +49.96% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $36.57 | +116.02% | 3 | Feb 23, 2024 |
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $163.56
Upside: +16.17%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $13.67
Upside: -4.90%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $70.47
Upside: +6.43%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $60.73
Upside: -6.14%
Align Technology
May 1, 2025
Maintains: Overweight
Price Target: $255 → $246
Current: $189.00
Upside: +30.16%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $74.80
Upside: +0.27%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $16.75
Upside: +13.43%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $59.01
Upside: +57.60%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $18.55
Upside: +13.21%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $13.37
Upside: -2.77%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $12.67
Upside: +49.96%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $36.57
Upside: +116.02%